Cell & Gene Therapies: Addressing Manufacturing Challenges to Accelerate Innovation

Wednesday, October 25, 2023 9:15 AM to 9:35 AM · 20 min. (Africa/Abidjan)

CPHI Content Hub - CC4.3

Conference

Future Therapies

Information

To watch on-demand, head over to CPHI Online. Click 'Events and Webinars' and find Event Content there. Presentations are shared at the speakers discretion.

SeqensSEQENS is a worldwide leader in the development and production of pharmaceutical solutions leveraging a strong industrial network, 10 R&D centers and 3,500 employees in 9 countries. As an integrated player across the value chain - from raw materials to active ingredients and from research and development to industrialization - SEQENS offers a broad portfolio of APIs, pharmaceutical intermediates and excipients.

Registered attendees

Alain Suurkask

Chief Business OfficerTulevik Consulting Inc.

Almira Bartolome

Executive Director, Commercial Development, Advanced Therapies and VaccinesFUJIFILM Diosynth Biotechnologies

Ana Maqueda

PfizerPfizer Inc.

Cell & Gene Therapies: Addressing Manufacturing Challenges to Accelerate Innovation

Information

Registered attendees

Log in

Log in